275 related articles for article (PubMed ID: 35933572)
21. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
[TBL] [Abstract][Full Text] [Related]
22. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
23. Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans.
Klaassen Z; Stock S; Waller J; De Hoedt A; Freedland SJ
JAMA Oncol; 2022 Jun; 8(6):914-918. PubMed ID: 35389461
[TBL] [Abstract][Full Text] [Related]
24. Double reading of automated breast ultrasound with digital mammography or digital breast tomosynthesis for breast cancer screening.
Lee JM; Partridge SC; Liao GJ; Hippe DS; Kim AE; Lee CI; Rahbar H; Scheel JR; Lehman CD
Clin Imaging; 2019; 55():119-125. PubMed ID: 30807927
[TBL] [Abstract][Full Text] [Related]
25. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area.
Solla Negrao EM; Cabello C; Conz L; Mauad EC; Zeferino LC; Vale DB
J Med Screen; 2023 Mar; 30(1):42-46. PubMed ID: 36071628
[TBL] [Abstract][Full Text] [Related]
26. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.
Conant EF; Zuckerman SP; McDonald ES; Weinstein SP; Korhonen KE; Birnbaum JA; Tobey JD; Schnall MD; Hubbard RA
Radiology; 2020 May; 295(2):285-293. PubMed ID: 32154771
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
Crivellaro P; Tafur M; George R; Muradali D
Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286
[TBL] [Abstract][Full Text] [Related]
28. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
[TBL] [Abstract][Full Text] [Related]
29. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
[No Abstract] [Full Text] [Related]
30. The role of facility and patient mix factors on recovery of screening and diagnostic mammography volumes following the initial COVID-19 pandemic wave.
Lomahan S; Rauscher GH; Murphy AM
Cancer Med; 2023 May; 12(9):10877-10888. PubMed ID: 36924321
[TBL] [Abstract][Full Text] [Related]
31. Breast exam use during the protracted COVID-19 pandemic, by age, race, and geography.
Butler EN; Benefield T; Henderson L; Kuzmiak C; Pritchard M; Nyante S
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36951539
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer screening using digital breast tomosynthesis compared to digital mammography alone for Japanese women.
Ban K; Tsunoda H; Togashi S; Kawaguchi Y; Sato T; Takahashi Y; Nagatsuka Y
Breast Cancer; 2021 Mar; 28(2):459-464. PubMed ID: 33165757
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
Malmgren JA; Guo B; Atwood MK; Hallam P; Roberts LA; Kaplan HG
Breast Cancer Res Treat; 2023 Nov; 202(1):105-115. PubMed ID: 37584882
[TBL] [Abstract][Full Text] [Related]
34. Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis.
Ng JS; Hamilton DG
J Med Screen; 2022 Dec; 29(4):209-218. PubMed ID: 35593115
[TBL] [Abstract][Full Text] [Related]
35. Considerations to increase rates of breast cancer screening across populations.
Patt D; Gordan L; Patel K; Okon T; Ferreyros N; Markward N; Sullivan M; Burnett B; Getachew B; Harris C
Am J Manag Care; 2022 Apr; 28(3 Spec. No.):SP136-SP138. PubMed ID: 35285592
[TBL] [Abstract][Full Text] [Related]
36. Mammography, routine ultrasonography in pregnancy, and PSA screenings in Italy.
Favaretti C; De Pieri P
Int J Technol Assess Health Care; 2001; 17(3):358-68. PubMed ID: 11495379
[TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer Screening and Young Black Men: Can Early Communication Avoid Later Health Disparities?
Miller DB; Markt SC; Nguyen CT; Coleman OC
J Cancer Educ; 2022 Oct; 37(5):1460-1465. PubMed ID: 33689157
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in postpandemic trends in prostate-specific antigen screening.
Qian Z; Alexander J; Daniels D; Abdollah F; Cole AP; Iyer HS; Trinh QD
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38546486
[TBL] [Abstract][Full Text] [Related]
39. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
